Atherothrombotic Diseases: Clinical Trials

2 trials for Atherothrombotic Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 31Recruiting 1

Follow Atherothrombotic Diseases: new trials by email Literature Review of Atherothrombotic Diseases trials Research Report on Atherothrombotic Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease
Cardiovascular Polypill (Valsartan, Atorvastatin, Aspirin), Colchicine 0.5 mg, Usual Care Group - Atherothrombotic Diseases, Atherosclerotic Cardiovascular Disease (ASCVD)
Phase 3RecruitingHospital do Coracao77132025-06-122026-01-22
A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects
BMS 986141, Rifampin - Atherothrombotic Diseases
Phase 1CompletedBristol-Myers Squibb162016-11-012017-02-23

Narrower conditions

Atherosclerosis (1)

Broader conditions

Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Cardiovascular Diseases (1)  ·  Vascular Diseases (1)

Interventions

Aspirin (1)  ·  Atorvastatin (1)  ·  Colchicine (1)  ·  Rifampin (1)  ·  Valsartan (1)

Sponsors

Bristol-Myers Squibb (1)  ·  Hospital do Coracao (1)

Countries

Brazil (1)

Top investigators

Erlon Oliveira de Abreu-Silva, M.D (1)